Medication errors through a national pharmacovigilance database approach: A study for Malta

International Journal of Risk and Safety in Medicine

Volumn 25, Issue 1, 2013, Pages 17-27

  Tanti, Amy ^a   Camilleri, Miriam ^b   Bonanno, Patricia Vella ^a   Borg, John Joseph ^a  

^a Medicines Authority   (Malta)

^b Ministry for Health   (Malta)

Author keywords

medication errors; Pharmacovigilance; pharmacovigilance database

Indexed keywords

ANTIBIOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ADVERSE DRUG REACTION; AGED; ARTICLE; COMMUNITY; DRUG ADMINISTRATION; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; HUMAN; INAPPROPRIATE PRESCRIBING; MALTA; MEDICATION ERROR; PATIENT ATTITUDE; RETROSPECTIVE STUDY; TREATMENT DURATION;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MALTA; MEDICATION ERRORS; MIDDLE AGED; PHARMACOVIGILANCE; RETROSPECTIVE STUDIES;

EID: 84874555161     PISSN: 09246479     EISSN: 18786847     Source Type: Journal    
DOI: 10.3233/JRS-120582     Document Type: Article

References (18)

1. Phillips D, Bredder C. Morbidity and mortality from medical errors: An increasingly serious public health problem. Ann Rev Pub Health 2002;23:135-50.
2. World Alliance for Patient Safety. London Declaration: Patients for patient safety. 2006. [Accessed July 2010] www.who.int/entity/patientsafety/ information centre/Final London Declaration Feb06.pd
3. Green CF, Mottram DR, Rowe PH, Pirmohamed M. Adverse drug reactions as a cause of admission to an acute medical assessment unit: A pilot study. J Clin Pharm Ther 2000;25(5):355-61.
4. Van der Hooft CS, Sturkenboom MC, Kingma HJ, Stricker BH. Adverse drug reaction-related hospitalisations: A nationwide study in The Netherlands. Drug Saf 2006;29(2):161-68.
5. OmoriDM,PotykRP, KroenkeK. The adverse effects of hospitalization on drug regimens. Arch InternMed1991;151:1562- 64.
6. Boockvar K, Fishman E, Kay-Kyriacou C, Monias A, Gavi S, Cortes T. Adverse events due to discontinuations in drug use and dose changes in patients transferred between acute and long-term care facilities. Arch Intern Med. 2004;164:545-55. http://archinte.ama-assn.org/cgi/reprint/164/5/545.pdf [Accessed January 2010].
7. Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: Effects on health services utilisation, costs, and patient outcomes. In: The Cochrane Library, Issue 2. 2000; Oxford: Update Software
8. National Coordinating Council for Medication Error Reporting and Prevention. About Medication Errors: What is a Medication Error? 1996 [Accessed July 2010] http://www.nccmerp.org/aboutMedErrors.html
9. Alj L, Touzani M, Benkirane R, Edwards IR, Soulaymani R. Detecting medication errors in pharmacovigilance database: Capacities and limits. Int J Risk Saf Med. 2007;19:187-94.
10. Kunac D, TatleyM. Detecting medication errors in the New Zealand pharmacovigilance database: A retrospective analysis. Drug Saf 2011;34(1):59-71.
11. International conference on harmonisation on the clinical safety data management: Data elements for transmission of ICSRs, ICH, pp. 1-28, 2000. http://www.ema.europa.eu/docs/en GB/document library/Scientific guideline/ 2009/09/WC500002750.pdf (accessed 26/10/2012
12. Medical Dictionary for Regulatory Activities (MedDRA): Maintenance Services and Support Organisation (MSSO); updated July 2011 [Accessed August 2011] http://www.meddramsso.com/
13. Begaud B, Evreux J, Jouglard J. Imputabilite des effets inattendus ou toxiques des medicaments, Therape 40. 1985;111-8.
14. Mann RD, Andrews EB. Pharmacovigilance. John Wiley & Sons Ltd, Chichester; 2002.
15. Leape LL, Bates DW, Cullen DJ, Cooper J, Demonaco HJ, Gallivan T, Hallisey R, Ives J, Laird N, Laffel G, et al. Systems analysis of adverse drug events ADE Prevention Study Group. JAMA 1995;274(1):35-43.
16. Kaushal R. Using chart review to screen for medication errors and adverse drug events. American Journal of Health-System Pharmacy 2002;59(23):2323-5.
17. Kuitunen T, Kuisma P, Hoppu K. Medication errors made by health care professionals. Analysis of the Finnish Poison Information Centre data between 2000 and 2007; Eur J Clin Pharmacol 2008;64(8):769-74.
18. Borg JJ, Aislaitner G, Pirozynski M, Mifsud S. Strengthening and rationalising pharmacovigilance in the European Union. Where is Europe heading to? A review of the new EU legislation on Pharmacovigilance. Drug Saf 2011;1;34(3):187-97.